
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $180.5B | $261.5B | $381.3B | $316.6B | $284.3B | |
Revenue Growth (YoY) | -47.65% | 44.84% | 45.82% | -16.97% | -10.2% | |
Cost of Revenues | $193.5B | $225.7B | $302.5B | $269.4B | $238.4B | |
Gross Profit | -$13B | $35.8B | $78.8B | $47.2B | $45.9B | |
Gross Profit Margin | -7.2% | 13.71% | 20.66% | 14.91% | 16.16% | |
R&D Expenses | $907M | $815M | $1.1B | $1.3B | $1.1B | |
Selling, General & Admin | $9.9B | $11.3B | $12.9B | $13.4B | $12.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $12.5B | $13.6B | $15.7B | $16.5B | $15.9B | |
Operating Income | -$25.5B | $22.3B | $63.1B | $30.7B | $30B | |
Net Interest Expenses | $3.5B | $3.1B | $4.3B | $2.1B | $2.4B | |
EBT. Incl. Unusual Items | -$27B | $29.8B | $64.8B | $32.6B | $29.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$5.4B | $9.2B | $21.9B | $13B | $13.4B | |
Net Income to Company | -$27B | $29.8B | $64.8B | $32.6B | $29.9B | |
Minority Interest in Earnings | -$146M | -$529M | -$565M | -$277M | -$427M | |
Net Income to Common Excl Extra Items | -$21.7B | $20.1B | $42.3B | $19.4B | $16.1B | |
Basic EPS (Cont. Ops) | -$5.56 | $5.18 | $11.52 | $5.76 | $5.10 | |
Diluted EPS (Cont. Ops) | -$5.56 | $5.14 | $11.42 | $5.70 | $5.06 | |
Weighted Average Basic Share | $3.9B | $3.9B | $3.7B | $3.4B | $3.1B | |
Weighted Average Diluted Share | $3.9B | $3.9B | $3.7B | $3.4B | $3.2B | |
EBITDA | $2.2B | $56.5B | $92.6B | $60.4B | $61.7B | |
EBIT | -$22.8B | $33.4B | $70.2B | $37.3B | $34.8B | |
Revenue (Reported) | $180.5B | $261.5B | $381.3B | $316.6B | $284.3B | |
Operating Income (Reported) | -$25.5B | $22.3B | $63.1B | $30.7B | $30B | |
Operating Income (Adjusted) | -$22.8B | $33.4B | $70.2B | $37.3B | $34.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $55.7B | $84.2B | $87B | $72.5B | $69.2B | |
Revenue Growth (YoY) | -7.27% | 51.27% | 3.27% | -16.65% | -4.48% | |
Cost of Revenues | $47.1B | $67.1B | $69.2B | $58.3B | $56.5B | |
Gross Profit | $8.6B | $17.1B | $17.8B | $14.1B | $12.7B | |
Gross Profit Margin | 15.44% | 20.34% | 20.41% | 19.52% | 18.35% | |
R&D Expenses | $166M | $189M | $253M | $212M | $185M | |
Selling, General & Admin | $2.5B | $3.2B | $3.1B | $3B | $2.8B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.9B | $3.7B | $3.7B | $3.9B | $3.2B | |
Operating Income | $5.7B | $13.4B | $14B | $10.2B | $9.5B | |
Net Interest Expenses | $597M | $1.7B | $494M | $357M | $554M | |
EBT. Incl. Unusual Items | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.5B | $3.5B | $5.6B | $3.6B | $4.1B | |
Net Income to Company | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Minority Interest in Earnings | -$124M | -$203M | -$64M | -$82M | -$95M | |
Net Income to Common Excl Extra Items | $5.7B | $7.1B | $8.7B | $7.4B | $4.8B | |
Basic EPS (Cont. Ops) | $1.46 | $1.88 | $2.52 | $2.28 | $1.58 | |
Diluted EPS (Cont. Ops) | $1.44 | $1.86 | $2.50 | $2.26 | $1.58 | |
Weighted Average Basic Share | $3.9B | $3.8B | $3.5B | $3.2B | $3B | |
Weighted Average Diluted Share | $3.9B | $3.8B | $3.5B | $3.3B | $3B | |
EBITDA | $15B | $17.9B | $21.2B | $17.9B | $15.2B | |
EBIT | $9.1B | $12.5B | $15.5B | $12.2B | $10.1B | |
Revenue (Reported) | $55.7B | $84.2B | $87B | $72.5B | $69.2B | |
Operating Income (Reported) | $5.7B | $13.4B | $14B | $10.2B | $9.5B | |
Operating Income (Adjusted) | $9.1B | $12.5B | $15.5B | $12.2B | $10.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $176.2B | $290B | $384.1B | $302.1B | $281.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $184.3B | $243.3B | $304.7B | $258.5B | $238.5B | |
Gross Profit | -$8.1B | $46.7B | $79.4B | $43.6B | $42.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $830M | $839M | $1.1B | $1.2B | $1.1B | |
Selling, General & Admin | $9.9B | $12.1B | $12.7B | $13.4B | $12.3B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $12.5B | $14.4B | $15.7B | $16.7B | $15.2B | |
Operating Income | -$20.7B | $32.4B | $63.7B | $26.9B | $27.3B | |
Net Interest Expenses | $3.3B | $4.1B | $3.1B | $1.9B | $2.6B | |
EBT. Incl. Unusual Items | -$19.4B | $32.4B | $68.4B | $29.3B | $27.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.6B | $10.2B | $24.1B | $11B | $13.9B | |
Net Income to Company | -$19.4B | $32.4B | $68.4B | $29.3B | $27.8B | |
Minority Interest in Earnings | -$269M | -$608M | -$426M | -$296M | -$441M | |
Net Income to Common Excl Extra Items | -$16B | $21.6B | $43.9B | $18B | $13.5B | |
Basic EPS (Cont. Ops) | -$4.12 | $5.62 | $12.16 | $5.46 | $4.36 | |
Diluted EPS (Cont. Ops) | -$4.14 | $5.58 | $12.06 | $5.42 | $4.34 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $26.3B | $59.5B | $96.1B | $57B | $59B | |
EBIT | -$15.3B | $36.9B | $73.4B | $33.9B | $32.7B | |
Revenue (Reported) | $176.2B | $290B | $384.1B | $302.1B | $281.1B | |
Operating Income (Reported) | -$20.7B | $32.4B | $63.7B | $26.9B | $27.3B | |
Operating Income (Adjusted) | -$15.3B | $36.9B | $73.4B | $33.9B | $32.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $55.7B | $84.2B | $87B | $72.5B | $69.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $47.1B | $67.1B | $69.2B | $58.3B | $56.5B | |
Gross Profit | $8.6B | $17.1B | $17.8B | $14.1B | $12.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $166M | $189M | $253M | $212M | $185M | |
Selling, General & Admin | $2.5B | $3.2B | $3.1B | $3B | $2.8B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.9B | $3.7B | $3.7B | $3.9B | $3.2B | |
Operating Income | $5.7B | $13.4B | $14B | $10.2B | $9.5B | |
Net Interest Expenses | $597M | $1.7B | $494M | $357M | $554M | |
EBT. Incl. Unusual Items | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.5B | $3.5B | $5.6B | $3.6B | $4.1B | |
Net Income to Company | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Minority Interest in Earnings | -$124M | -$203M | -$64M | -$82M | -$95M | |
Net Income to Common Excl Extra Items | $5.7B | $7.1B | $8.7B | $7.4B | $4.8B | |
Basic EPS (Cont. Ops) | $1.46 | $1.88 | $2.52 | $2.28 | $1.58 | |
Diluted EPS (Cont. Ops) | $1.44 | $1.86 | $2.50 | $2.26 | $1.58 | |
Weighted Average Basic Share | $3.9B | $3.8B | $3.5B | $3.2B | $3B | |
Weighted Average Diluted Share | $3.9B | $3.8B | $3.5B | $3.3B | $3B | |
EBITDA | $15B | $17.9B | $21.2B | $17.9B | $15.2B | |
EBIT | $9.1B | $12.5B | $15.5B | $12.2B | $10.1B | |
Revenue (Reported) | $55.7B | $84.2B | $87B | $72.5B | $69.2B | |
Operating Income (Reported) | $5.7B | $13.4B | $14B | $10.2B | $9.5B | |
Operating Income (Adjusted) | $9.1B | $12.5B | $15.5B | $12.2B | $10.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $31.8B | $36.9B | $40.1B | $38.3B | $37.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $21.8B | $34.7B | $39.3B | $36.3B | $31B | |
Inventory | $19.5B | $25.3B | $31.9B | $26B | $23.4B | |
Prepaid Expenses | $3.7B | $9B | $14.5B | $6.2B | $5.7B | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $92B | $128.8B | $165.9B | $134.1B | $127.9B | |
Property Plant And Equipment | $209.7B | $194.9B | $198.6B | $194.8B | $185.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $14B | $14.9B | $16B | $16.7B | $16B | |
Other Intangibles | $8.7B | $9.8B | $9.7B | $10.3B | $9.5B | |
Other Long-Term Assets | $1M | -- | -- | -- | -$2M | |
Total Assets | $379.3B | $404.4B | $443B | $406.3B | $387.6B | |
Accounts Payable | $22.7B | $34.1B | $42.6B | $34.6B | $29.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.1B | $4.1B | $4.4B | $4.6B | $4.7B | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $73.7B | $95.5B | $121.3B | $95.5B | $95B | |
Long-Term Debt | $66.8B | $57.5B | $51.5B | $48.5B | $41.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $220.7B | $229.1B | $250.4B | $217.9B | $207.4B | |
Common Stock | $651M | $641M | $584M | $544M | $510M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $155.3B | $172B | $190.5B | $186.6B | $178.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3.2B | $3.4B | $2.1B | $1.8B | $1.9B | |
Total Equity | $158.5B | $175.3B | $192.6B | $188.4B | $180.2B | |
Total Liabilities and Equity | $379.3B | $404.4B | $443B | $406.3B | $387.6B | |
Cash and Short Terms | $31.8B | $36.9B | $40.1B | $38.3B | $37.8B | |
Total Debt | $79.6B | $61.6B | $56.2B | $53.8B | $48.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $31B | $38.4B | $42.1B | $39.9B | $35.6B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $40.1B | $63.5B | $61.7B | $53.2B | $48.2B | |
Inventory | $22.7B | $30B | $28.6B | $26.5B | $23B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $1M | $1M | -- | |
Total Current Assets | $99.6B | $152B | $150.6B | $133.1B | $126.7B | |
Property Plant And Equipment | $208.3B | $193.3B | $199.2B | $192B | $183.7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | $9.8B | $16.6B | $16.1B | |
Other Intangibles | -- | -- | $17.7B | $10B | $11.4B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $385.4B | $425B | $429.2B | $402B | $389.2B | |
Accounts Payable | $49.5B | $71.7B | $68.9B | $66B | $60.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -$1M | -- | |
Total Current Liabilities | $76.4B | $113.3B | $102.7B | $93.9B | $96.1B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $218.4B | $245.5B | $233.6B | $213.7B | $208.6B | |
Common Stock | $651M | $630M | $572M | $537M | $502M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3.2B | $3.5B | $2.2B | $1.7B | $1.9B | |
Total Equity | $167B | $179.5B | $195.5B | $188.3B | $180.7B | |
Total Liabilities and Equity | $385.4B | $425B | $429.2B | $402B | $389.2B | |
Cash and Short Terms | $31B | $38.4B | $42.1B | $39.9B | $35.6B | |
Total Debt | $102.4B | $86B | $85.1B | $79.9B | $76.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$27B | $29.8B | $64.8B | $32.6B | $29.9B | |
Depreciation & Amoritzation | $25B | $23.1B | $22.4B | $23.1B | $26.9B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $9.6B | -$20.6B | -$9B | $12.4B | $6.6B | |
Change in Inventories | $4.5B | -$7.3B | -$8.4B | $6.3B | $1.3B | |
Cash From Operations | $34.1B | $45.1B | $68.4B | $54.2B | $54.7B | |
Capital Expenditures | $16.6B | $19B | $22.6B | $23B | $19.6B | |
Cash Acquisitions | $216M | $105M | -$1.5B | -$728M | -$814M | |
Cash From Investing | -$13.3B | -$4.8B | -$22.4B | -$17.7B | -$15.2B | |
Dividends Paid (Ex Special Dividend) | -$7.4B | -$6.3B | -$7.4B | -$8.4B | -$8.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $23B | $1.8B | $269M | $1B | $363M | |
Long-Term Debt Repaid | -$17.4B | -$21.5B | -$8.5B | -$10.7B | -$9.7B | |
Repurchase of Common Stock | -$2.1B | -$3.2B | -$19B | -$15.5B | -$14.7B | |
Other Financing Activities | $1.1B | -$1.1B | -$3.8B | $701M | -$609M | |
Cash From Financing | -$7.2B | -$34.7B | -$42B | -$38.2B | -$38.4B | |
Beginning Cash (CF) | $18.1B | $31.8B | $37B | $40.2B | $38.8B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $13.6B | $5.7B | $4B | -$1.8B | $1.1B | |
Ending Cash (CF) | $31.8B | $37B | $40.2B | $38.8B | $39.1B | |
Levered Free Cash Flow | $17.5B | $26.1B | $45.8B | $31.2B | $35.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Depreciation & Amoritzation | $5.9B | $5.4B | $5.7B | $5.7B | $5.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$6.8B | -$10B | $5.9B | -$195M | -$2.6B | |
Change in Inventories | -$3.4B | -$4.9B | $4.2B | -$608M | $854M | |
Cash From Operations | $8.3B | $14.8B | $14.2B | $13.3B | $9.3B | |
Capital Expenditures | $3.9B | $4.2B | $6.2B | $4B | $3.7B | |
Cash Acquisitions | $206M | -$617M | -$50M | -$367M | -$380M | |
Cash From Investing | -$590M | -$4.3B | -$4.2B | -$3.5B | -$4B | |
Dividends Paid (Ex Special Dividend) | -$1.3B | -$2B | -$2B | -$2.2B | -$2.2B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $109M | $101M | $415M | $167M | $139M | |
Long-Term Debt Repaid | -$5.7B | -$2.5B | -$1.5B | -$1.5B | -$2.5B | |
Repurchase of Common Stock | -$279M | -$3.6B | -$4.5B | -$3.3B | -$4.1B | |
Other Financing Activities | -$433M | -$481M | $170M | -$301M | $302M | |
Cash From Financing | -$8.4B | -$9B | -$8.4B | -$8.2B | -$9.2B | |
Beginning Cash (CF) | $31.8B | $37B | $40.2B | $38.8B | $39.1B | |
Foreign Exchange Rate Adjustment | -$128M | -$134M | $293M | -$379M | $353M | |
Additions / Reductions | -$716M | $1.5B | $1.5B | $1.6B | -$3.9B | |
Ending Cash (CF) | $31B | $38.4B | $42.1B | $39.9B | $35.6B | |
Levered Free Cash Flow | $4.4B | $10.6B | $8B | $9.4B | $5.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$19.4B | $32.4B | $68.4B | $29.3B | $27.8B | |
Depreciation & Amoritzation | $23.8B | $22.6B | $22.7B | $23.1B | $26.3B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$3.5B | -$23.7B | $7B | $6.3B | $4.2B | |
Change in Inventories | -$8.5B | -$8.8B | $771M | $1.5B | $2.7B | |
Cash From Operations | $27.5B | $51.6B | $67.8B | $53.4B | $50.6B | |
Capital Expenditures | $16.2B | $19.4B | $24.5B | $20.8B | $19.4B | |
Cash Acquisitions | $434M | -$718M | -$895M | -$1B | -$827M | |
Cash From Investing | -$11.2B | -$8.4B | -$22.4B | -$17B | -$15.6B | |
Dividends Paid (Ex Special Dividend) | -$5.2B | -$6.9B | -$7.5B | -$8.6B | -$8.6B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $22.1B | $1.8B | $583M | $781M | $335M | |
Long-Term Debt Repaid | -$20.4B | -$18.4B | -$7.4B | -$10.7B | -$10.7B | |
Repurchase of Common Stock | -$695M | -$6.5B | -$20B | -$14.3B | -$15.5B | |
Other Financing Activities | $770M | -$1.2B | -$3.1B | $230M | -$6M | |
Cash From Financing | -$7.9B | -$35.3B | -$41.3B | -$38.1B | -$39.4B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8.5B | $7.9B | $4B | -$1.8B | -$4.3B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $11.3B | $32.3B | $43.2B | $32.6B | $31.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.2B | $10.8B | $14.4B | $11B | $9B | |
Depreciation & Amoritzation | $5.9B | $5.4B | $5.7B | $5.7B | $5.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$6.8B | -$10B | $5.9B | -$195M | -$2.6B | |
Change in Inventories | -$3.4B | -$4.9B | $4.2B | -$608M | $854M | |
Cash From Operations | $8.3B | $14.8B | $14.2B | $13.3B | $9.3B | |
Capital Expenditures | $3.9B | $4.2B | $6.2B | $4B | $3.7B | |
Cash Acquisitions | $206M | -$617M | -$50M | -$367M | -$380M | |
Cash From Investing | -$590M | -$4.3B | -$4.2B | -$3.5B | -$4B | |
Dividends Paid (Ex Special Dividend) | -$1.3B | -$2B | -$2B | -$2.2B | -$2.2B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $109M | $101M | $415M | $167M | $139M | |
Long-Term Debt Repaid | -$5.7B | -$2.5B | -$1.5B | -$1.5B | -$2.5B | |
Repurchase of Common Stock | -$279M | -$3.6B | -$4.5B | -$3.3B | -$4.1B | |
Other Financing Activities | -$433M | -$481M | $170M | -$301M | $302M | |
Cash From Financing | -$8.4B | -$9B | -$8.4B | -$8.2B | -$9.2B | |
Beginning Cash (CF) | $31.8B | $37B | $40.2B | $38.8B | $39.1B | |
Foreign Exchange Rate Adjustment | -$128M | -$134M | $293M | -$379M | $353M | |
Additions / Reductions | -$716M | $1.5B | $1.5B | $1.6B | -$3.9B | |
Ending Cash (CF) | $31B | $38.4B | $42.1B | $39.9B | $35.6B | |
Levered Free Cash Flow | $4.4B | $10.6B | $8B | $9.4B | $5.5B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.